Login to Your Account

Biogen Idec's Antegren Positive In Maintenance Trial For Crohn's

By Karen Pihl-Carey

Friday, January 30, 2004
Despite a failed trial last year, Antegren now has garnered some positive Phase III data, meeting its primary endpoint by maintaining a response in Crohn's disease patients. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription